GBA Presents: RADIO SAVANT-!

Discussion in 'Stocks' started by stonedinvestor, May 13, 2022.

  1. B>R>E>A>K>I>N>G NEWS!

    China lying about coming out of zero Covid restrictions?

     
    #9941     Nov 15, 2022
  2. vanzandt

    vanzandt

    Stoney, and you lost 10% on the bid/ask spread.
    These penny stocks are stupid.
    Try to keep things above $7 for thread integrity. I shouldn't have even posted Gingko.
     
    #9942     Nov 15, 2022
  3. Bad news.My wife goes to this building for her work a few times a week...

     
    #9943     Nov 15, 2022


  4. Van How can I lose money without buy yet? Only you can dream up these scenarios...

    Wait for GO TIME
     
    #9944     Nov 15, 2022
  5. vanzandt

    vanzandt

    The real breaking news will turn out to be... Biden talked XI into using Moderna or Pfizer
    ~the savant
     
    #9945     Nov 15, 2022
  6. vanzandt

    vanzandt

    Just going by what you said.
    I can't keep up.

     
    #9946     Nov 15, 2022
  7. Is this some sort of competition to CHWY?

     
    #9947     Nov 15, 2022


  8. We have offered. But they will steal the technology so MRNA is only half way in on the concept. Initially they were gung ho for China>
     
    #9948     Nov 15, 2022
  9. Just going by what you said.



    <<2 Possible Gummies>>


    Kodiak Sciences initiated with an Overweight at Capital One 08:27 KOD Capital One analyst Zegbeh Jallah initiated coverage of Kodiak Sciences with an Overweight rating and $24 price target. Kodiak's long-acting anti-VEGF drug Tarcocimab, or KSI-301, is currently in Phase 3 studies for DME, wAMD and NPDR with data expected in 2023, Jallah tells investors. Data from the Phase 3 BEACON study presented in September reaffirmed KSI-301's longer-acting potential and clean safety profile and "sets positive expectations for the 2023 readouts," but Jallah believes that macro events affecting the market and a "flight of investors out of the biotech sector" led to a muted reaction to the data, the analyst added.


    KOD
    $7.25-0.31(-4.10%)11:00 AM 11/14/22
    NASDAQ |$USD |Pre-Market:$7.51+0.26(+3.59%)3:48 AM


    Small reaction-
    /////////////////////
    NeuroSense rises 16% on U.S. FDA clearance to begin trial of ALS treatment

    Watch For Gummy!// wait for GO TIME<---------:caution::caution::caution::caution::caution:

    NRSN
    $1.580.06(+4.30%)10:59 AM 11/14/22
    NASDAQ |$USD |Pre-Market:$1.74+0.17(+10.48%)<----------:caution:

    BUY VAN!!!!!

    & Sell! Just made you 5% :D

    NRSN NeuroSense Therapeutics Ltd.


    $1.580.06(+4.30%)10:59 AM 11/14/22
    NASDAQ |$USD |Pre-Market:$1.81+0.24(+14.92%)4:15 AM
     
    #9949     Nov 15, 2022
  10. You really like to mindfuck me Why? Last huge gummy we had was for 60% in 1 day and you found some problem with that -wasn't sure when to buy... I'm not buying your naivete
    or or pretend lack of knowledge.. so I go out of my way to scream the obvious I always do wait for my signal on the retrace...

    and you pretend you read the opposite -- that your a dummy again...

    just not buying it....
     
    #9950     Nov 15, 2022